乳腺癌中的代谢调节非编码RNA:作用,机制和临床应用
Shiliang Xu1, Lingxia Wang1, Yuexin Zhao1
1Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215004, People's Republic of China.
Journal of biomedical science
|February 26, 2024
概括
本综述探讨了非编码RNAs (ncRNAs) 如何调节乳腺癌中的新陈代谢. 这些ncRNAs对于理解和潜在地治疗各种癌症疗法和耐药性至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 乳腺癌是妇女死亡的主要原因,其特点是代谢重编程.
- 瘤细胞表现出增强的代谢过程,利用营养物质进行增殖和进展.
- 非编码RNAs (ncRNAs) 是基因表达的关键调节者,影响细胞代谢.
研究的目的:
- 审查乳腺癌中ncRNAs的代谢调节机制.
- 探索调节代谢的ncRNAs在乳腺癌治疗中的临床应用.
- 讨论ncRNAs在治疗耐药性的作用及其作为生物标志物的潜力.
主要方法:
- 文献综述侧重于乳腺癌中代谢调节的ncRNAs.
- 对ncRNA参与关键代谢途径 (糖解,谷氨酸解,脂肪酸合成) 的分析.
- 检查ncRNA在内分泌,向,化疗,免疫疗法和放射疗法耐药性中的作用.
主要成果:
- 调节新陈代谢的ncRNA在乳腺癌的进展和恶性瘤中起着关键作用.
- 这些ncRNAs与对各种乳腺癌疗法的耐药性有关.
- ncRNAs显示出作为乳腺癌管理的治疗标和生物标记物的潜力.
结论:
- 准新陈代谢调节的ncRNAs为乳腺癌提供了有前途的治疗策略.
- 了解ncRNA功能对于克服治疗耐药性至关重要.
- 需要进一步的研究来解决目前基于ncRNA的治疗方法的挑战.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
Types of RNA
63.7K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.7K


